Edmond de Rothschild Holding’s Kite Pharma, Inc. KITE Stock Holding History

Edmond de Rothschild Holding’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$45K	–	900
2016 Q4	$45K	Hold	1,000	–	–	﹤0.01%	662
2016 Q3	$56K	Hold	1,000	–	–	﹤0.01%	653
2016 Q2	$50K	Hold	1,000	–	–	﹤0.01%	642
2016 Q1	$46K	Hold	1,000	–	–	﹤0.01%	646
2015 Q4	$62K	Hold	1,000	–	–	﹤0.01%	607
2015 Q3	$56K	Buy	+1,000	New	+$62.9K	﹤0.01%	610

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Edmond de Rothschild Holding's KITE Position: Q1 2017 in Review

Edmond de Rothschild Holding sold out of Kite Pharma, Inc. (KITE) in Q1 2017, closing a stake of 1,000 shares — an estimated $45K sold.

Edmond de Rothschild Holding first reported a position in KITE in Q3 2015 and held it in 6 quarters. The position peaked at $62K in Q4 2015. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

Edmond de Rothschild Holding reported no remaining Kite Pharma, Inc. position as of Q1 2017 after selling out during the quarter.
Edmond de Rothschild Holding sold 1,000 Kite Pharma, Inc. shares in Q1 2017, an estimated $45K.
Edmond de Rothschild Holding first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 6 quarters.
Edmond de Rothschild Holding's Kite Pharma, Inc. position peaked at $62K in Q4 2015.
209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2017, filed 15 May 2017.